162928-03-2: Selexipag TDA Impurity
Selexipag O Impurity / Selexipag TDA Impurity (CAS No: 162928-03-2) or Tert-butyl 2-((5,6-diphenylpyrazin-2-yl)oxy)acetate, is a selective prostacyclin receptor agonist that used to treat pulmonary arterial hypertension.
Additional information on CAS 162928-03-2
Catalogue No.
VL4020004
CAS No.
162928-03-2
Molecular Formula
C22H22N2O3
Molecular Weight
362.42
Parent drug
Selexipag
IUPAC Name
Tert-butyl 2-((5, 6-diphenylpyrazin-2-yl)oxy)acetate;
Synonyms
Selexipag O Impurity
References
Coghlan, J. Gerry, et al. “Selexipag in the Management of Pulmonary Arterial Hypertension: An Update.” Drug, Healthcare and Patient Safety, vol. Volume 11, Aug. 2019, pp. 55–64, https://doi.org/10.2147/dhps.s181313. ?
Status
In-stock
